|
|
|
|
|
by risaacs99
2231 days ago
|
|
I keep reading people asserting this, and I assume it's because we believe that a virus that becomes less lethal would have an evolutionary advantage. But, wouldn't lengthening the incubation period also be a successful evolutionary strategy regardless of lethality? It seems to me that there are many possible strategies that a mutating virus might gain an advantage and we shouldn't just assume that the only one that they would use would be to become more mild. Luckily, sars-cov-2 seems relatively stable. |
|
> Trade-offs between different components of parasite fitness provide the dominant conceptual framework for understanding the adaptive evolution of virulence (Alizon et al. 2009).
...
> By far, the most widely studied trade-off involves transmission and virulence (Anderson and May, 1982; Frank, 1996; Alizon et al. 2009). Transmission and virulence are linked by within-host replication: increasing parasite abundance increases the likelihood of transmission, but also increases the likelihood of host death; mathematically, this assumption can be formalized by making transmission rate β an increasing function of parasite-induced mortality rate ν. Nearly all of the literature we summarize below assumes this trade-off. However, another potential trade-off suggested by an examination of R0 involves virulence and recovery rate (Anderson and May, 1982; Frank, 1996). This trade-off is also mediated by replication rate, with high abundance increasing the likelihood of host death, but also decreasing the likelihood of the host clearing the infection (Antia et al. 1994); mathematically, this assumption makes recovery rate γ a decreasing function of parasite-induced mortality rate ν.